Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2025-12-25 @ 4:49 AM
NCT ID:
NCT01176318
Eligibility Criteria:
Inclusion Criteria:
* Male/females aged between 40-80 years
* Previous diagnosis of COPD
* Acute exacerbation of COPD requiring treatment with antibiotics and/or corticosteroids
* Symptoms of increased breathlessness, cough, sputum volume or sputum purulence
* Acute exacerbation of COPD hospitalised within 24hrs of study participation.
* On a stable therapeutic regimen for COPD for 8 weeks prior to inclusion
* Known history of cigarette smoking at least 10 pack yrs
* Willing and able to comply with study procedures
* Able to provide written informed consent to participate
Exclusion Criteria:
* Acute exacerbation of COPD within 8 weeks prior to inclusion
* Arterial blood gas on admission \< pH 7.26
* Currently on treatment with mucolytics
* Patients suffering from post nasal drip, or gastro-oesophageal reflux disease
* Clinically significant or unstable concurrent disease e.g. left ventricular failure, diabetes mellitus
* On long-term oxygen therapy
* Known or suspected hypersensitivity to erdosteine
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT01176318
Study Brief:
Protocol Section:
NCT01176318